News

BioCardia's CardioAMP heart failure cell therapy.

Funds with help bring its cellular therapeutics to market in the next year.

ASE guidelines summary of recommended imaging steps for performance of M-TEER.

The new guideline emphasizes the importance of 3D multiplanar reconstruction for M-TEER to increase precision.

cleveland clinic settles for failing to disclose research funding

Judge Leo T. Sorkin on June 8 declared the charge unlawful, contending it “exceeds the fee-setting authority delegated by Congress.” 

Approximately 1,470 of active radiologist openings have been sitting unfilled for over two months or more, concentrated in certain states. 

job interview

“Interventional Radiology training inherently involves specialty-specific characteristics that make in-person interviews particularly valuable,” the APDIR contends. 

texting

Many patients mistake auto-text messages from providers as opportunities to interact with the sender. When this happens, the patient often tries to communicate about more than just appointment scheduling. 

Emergency Department room ED ER EM

A coalition of municipalities and nonprofits is challenging the changes to the Affordable Care Act, arguing that low-cost, low-value coverage options flooding the market will ultimately cause 3 million people to lose their necessary medical insurance. 

Breast arterial calcifications (BACs) identified on screening mammograms may help identify women who face a heightened risk of developing cardiovascular disease (CVD), according to a new analysis published in Clinical Imaging.

Experts say these findings could offer radiology providers the opportunity to intervene before cardiovascular conditions worsen.

Abbott's Navitor TAVR valve

Abbott's TAVR valve now has CE mark approval for treating low-, intermediate- and high-risk patients who present with symptomatic severe aortic stenosis. The news comes as new data on the valve's safety and effectiveness were just published in JACC: Cardiovascular Interventions.

Recor Medical's Paradise Ultrasound Renal Denervation System

Recor Medical's Paradise Ultrasound Renal Denervation System is the first medical device approved for the treatment of hypertension in Japan. It first gained FDA approval back in 2023.

Thumbnail

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%. 

GE HealthCare Vivid Pioneer cardiovascular ultrasound

The company describes Vivid Pioneer as its “most advanced, ultra-premium and adaptive cardiovascular ultrasound system yet.” It includes new and improved AI capabilities and a compact design that is still fully functional in tight workspaces. 

Around the web

Funds with help bring its cellular therapeutics to market in the next year.

The new guideline emphasizes the importance of 3D multiplanar reconstruction for M-TEER to increase precision.

Judge Leo T. Sorkin on June 8 declared the charge unlawful, contending it “exceeds the fee-setting authority delegated by Congress.”